Liberate Bio bags key CAR-M patents, eyes first clinical trials in 2026
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
The new patents cover critical advancements in cochlear implant technology
The portfolio includes foundational patents on the production, composition, and commercial use of NR
Marks remarkable acceleration in innovation using AI technology
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
Decisions reaffirm the ability of Biocon Biologics and Viatris to provide patient access to interchangeable Semglee
The protections extend through at least 2035, with the potential for further extensions
The Japanese Patent Office has issued a favorable Appeal Decision granting a patent for the use of REQORSA Gene Therapy in combination with PD-L1 antibodies to treat cancer
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
Subscribe To Our Newsletter & Stay Updated